Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study to Compare the Efficacy and Safety of YL201 With Standard Chemotherapy in Patients With Metastatic Pancreatic Cancer After Failure of Gemcitabine-Based Systemic Chemotherapy

MediLink Therapeutics (Suzhou) Co., Ltd. · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
metastatic pancreatic cancer, pancreatic ductal adenocarcinoma (pdac), yl201, tambotatug pelitecan, tam-peli, pdac, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 848375
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.